CAS No. |
235114-32-6 |
|---|---|
英文名称 |
5-((1S,2S)-2-((2R,9S,11R,12R,14aS,15S,16S,20S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)-2,11,12,15-tetrahydroxy-6-((R)-1-hydroxyethyl)-16-methyl-5,8,14,19,22,25-hexaoxo-9-(4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzamido)tetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-23-yl)-1,2-dihydroxyethyl)-2-hydroxyphenyl hydrogen sulfate |
别名 |
MICAFUNGIN;Micfungin;PubChem ID: 11804463;PubChem ID: 122130057;PubChem ID: 477468;PubChem ID: 78357831;PubChem ID: 3081921;Micafungin (Acid) |
标准英文名 |
5-((1S,2S)-2-((2R,9S,11R,12R,14aS,15S,16S,20S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)-2,11,12,15-tetrahydroxy-6-((R)-1-hydroxyethyl)-16-methyl-5,8,14,19,22,25-hexaoxo-9-(4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzamido)tetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-23-yl)-1,2-dihydroxyethyl)-2-hydroxyphenyl hydrogen sulfate |
分子式 |
C56H71N9O23S |
分子量 |
1270.29 |
精确分子量 |
1269.44 |
SMILES |
CCCCCOC1=CC=C(C2=CC(C3=CC=C(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)C([C@H](O)[C@@H](O)C5=CC(OS(=O)(=O)O)=C(O)C=C5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)C([C@@H](C)O)NC4=O)C=C3)=NO2)C=C1 |
标准SMILES |
CCCCCOC1C=CC(=CC=1)C1=CC(=NO1)C1C=CC(=CC=1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)C(NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)C(NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1C=CC(O)=C(C=1)OS(O)(=O)=O)[C@H](O)CC(N)=O |
用途 |
Micafungin is primarily used for the treatment of esophageal candidiasis and for prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation. It is also indicated for the treatment of refractory invasive fungal infections or invasive candidiasis and invasive aspergillosis in patients who are intolerant to or have failed other antifungal therapies. Additionally, micafungin exhibits activity against Pneumocystis species. |
InChIKey |
PIEUQSKUWLMALL-LXWXBMNESA-N |
|
|
评论 |
|---|